Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to -$84.1 million.

  • Surgery Partners' Cash from Financing Activities fell 105205.48% to -$84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.5 million, marking a year-over-year decrease of 14043.68%. This contributed to the annual value of $262.0 million for FY2024, which is 26881.44% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Cash from Financing Activities is -$84.1 million, which was down 105205.48% from -$62.6 million recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Cash from Financing Activities peaked at $229.8 million during Q4 2021, and registered a low of -$84.1 million during Q3 2025.
  • Its 5-year average for Cash from Financing Activities is $18.4 million, with a median of -$41.2 million in 2023.
  • As far as peak fluctuations go, Surgery Partners' Cash from Financing Activities surged by 60174.67% in 2021, and later crashed by 105205.48% in 2025.
  • Over the past 5 years, Surgery Partners' Cash from Financing Activities (Quarter) stood at $229.8 million in 2021, then decreased by 15.97% to $193.1 million in 2022, then tumbled by 123.1% to -$44.6 million in 2023, then soared by 207.62% to $48.0 million in 2024, then plummeted by 275.21% to -$84.1 million in 2025.
  • Its last three reported values are -$84.1 million in Q3 2025, -$62.6 million for Q2 2025, and $30.2 million during Q1 2025.